Solventum Corporation (SOLV)
NYSE: SOLV · IEX Real-Time Price · USD
61.56
-0.88 (-1.41%)
At close: May 16, 2024, 4:00 PM
61.55
-0.01 (-0.02%)
After-hours: May 16, 2024, 7:49 PM EDT

Company Description

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.

It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.

The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents.

The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms.

The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes.

The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Solventum Corporation
Solventum logo
Country United States
Founded 2023
Industry Health Information Services
Sector Healthcare
Employees 22,000
CEO Bryan C. Hanson

Contact Details

Address:
C/o 3m Company, 3m Center, Building 275-6w-02
St. Paul, Minnesota 55144-1000
United States
Phone 651-733-1110
Website solventum.com

Stock Details

Ticker Symbol SOLV
Exchange NYSE
Fiscal Year January - December
CIK Code 0001964738
CUSIP Number 83444M101
ISIN Number US83444M1018
Employer ID 92-2008841
SIC Code 3841

Key Executives

Name Position
Mary T. Wilcox Chief Accounting Officer
Amy Landucci Chief Information and Digital Officer
Paul S. Harrington Chief Supply Chain Officer
Michael J. Ottesen Vice President

Latest SEC Filings

Date Type Title
May 10, 2024 10-Q Quarterly Report
May 9, 2024 8-K Current Report
Apr 16, 2024 8-K Current Report
Apr 4, 2024 8-K Current Report
Apr 1, 2024 S-8 Securities to be offered to employees in employee benefit plans
Mar 13, 2024 8-K Current Report
Mar 12, 2024 CERT Certification by an exchange approving securities for listing
Mar 11, 2024 10-12B/A Filing
Mar 6, 2024 10-12B/A Filing
Mar 1, 2024 UPLOAD Filing